<DOC>
	<DOCNO>NCT00437983</DOCNO>
	<brief_summary>The primary objective trial ass ability oral administration Phosphatidylserine-Omega3 improve attention memory complaint comparison placebo age associate memory impaired subject .</brief_summary>
	<brief_title>The Efficacy Phosphatidylserine-Omega3 Elderly With Age Associated Memory Impairment</brief_title>
	<detailed_description />
	<mesh_term>Memory Disorders</mesh_term>
	<criteria>1 . Ability give write informed consent 2 . Age : 90≥ year ≥50 3 . Gender : male female 4 . CDR ≤ 0.5 5 . Complaints memory loss reflect everyday problem difficulty remember name individual follow introduction , misplace object , difficulty remember multiple item purchase multiple task perform , difficulty remember telephone number zip code , difficulty recall information quickly follow distraction . Onset memory loss must describe gradual , without sudden worsen recent month . Complaints memory loss assess MACQ scale . 6 . MiniMental State Examination ( MMSE ) ≥27 subject college education ( BA ) ≥ 26 others 7 . Memory test performance least 1 SD mean establish young adult least one neuropsychological subtest NexAde . 8 . Language : Subjects must able read , write speak Hebrew . 9 . Ability perform test interview 1 . Evidence delirium , confusion , disturbances consciousness 2 . Any Neurological disorder could produce cognitive deterioration . Such disorder include AD , Parkinson 's disease , stroke , intracranial hemorrhage , local brain lesion include tumor , normal pressure hydrocephalus 3 . History infective inflammatory brain disease include viral , fungal , syphilitic etiology 4 . Evidence significant cerebral vascular pathology 5 . Head injury immediately precede cognitive deterioration . 6 . Current psychiatric diagnosis accord DSM IV criterion depression , mania , major psychiatric disorder 7 . Current diagnosis history alcoholism drug dependence . 8 . Evidence depression determine Geriatric Depression Scale ( short version ) score 5 . 9 . Any medical disorder could produce cognitive deterioration include renal , respiratory , cardiac , hepatic disease , diabetes mellitus , endocrine , metabolic hematological disturbance unless well control , malignancy remission two year 10 . Use psychotropic drug drug supplement may significantly affect cognitive function month prior psychometric test . 11 . Use experimental medication within 1 month prior screen concomitant medication . 12 . Subject history hypersensitivity allergy fish fish oil soy .</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>January 2010</verification_date>
</DOC>